Diabetes 51:S103-S108, 2002
© 2002 by the American Diabetes Association, Inc.
Section 3: Phasic Insulin Release and Metabolic Control |
Physiological Consequences of Phasic Insulin Release in the Normal Animal
Alan D. Cherrington1,
Dana Sindelar2,
Dale Edgerton1,
Kurt Steiner3, and
Owen P. McGuinness1
1 Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee
2 Department of Eli Lilly and Company, Indianapolis, Indiana
3 Department of Biological Research, Wyeth Ayerst Laboratories, Radnor, Pennsylvania
The dose-response relationship between the hepatic sinusoidal insulin level and glucose production by the liver is such that a half-maximally effective concentration is at or slightly below the hormone levels seen basally after an overnight fast. In the normal individual, the direct effect of the hormone on the hepatocyte is far more important in restraining glucose production than its indirect effect mediated via a suppression of lipolysis. Because insulin regulates the liver in a direct fashion, its effect occurs within several minutes. Thus, the speed with which insulin works and the sensitivity of the liver to it predict that first-phase insulin release should have a significant effect in quickly suppressing hepatic glucose production. On the other hand, nonhepatic tissues are much less sensitive to insulin and respond slowly as a result of the need for insulin to cross the endothelial barrier. As a result, first-phase insulin is unlikely to significantly alter peripheral glucose disposal. Simulation studies in humans and dogs in which the effects of first-phase insulin were simulated confirmed the aforementioned predictions. In addition, they confirmed the ability of second-phase insulin release to have significant effects on both glucose production and utilization.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Connolly, T. Papa, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore
Hepatic and muscle insulin action during late pregnancy in the dog
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2007;
292(1):
R447 - R452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Batista, M. S. Smith, W. L. Snead, C. C. Connolly, D. B. Lacy, and M. C. Moore
Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2005;
289(4):
R1064 - R1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Chen, C. J. Torres-Sanchez, N. Hosein, Y. Zhang, D. B. Lacy, and O. P. McGuinness
Time course of the hepatic adaptation to TPN: interaction with glycogen depletion
Am J Physiol Endocrinol Metab,
January 1, 2005;
288(1):
E163 - E170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E371 - E385.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|